| Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans LL Liu, J Landskron, EH Ask, M Enqvist, E Sohlberg, JA Traherne, ... Cell reports 15 (5), 1088-1099, 2016 | 228 | 2016 |
| Remodeling of secretory lysosomes during education tunes functional potential in NK cells JP Goodridge, B Jacobs, ML Saetersmoen, D Clement, Q Hammer, ... Nature communications 10 (1), 514, 2019 | 118 | 2019 |
| Use of expression profiles of HBV-DNA integrated into genomes of hepatocellular carcinoma cells to select T cells for immunotherapy AT Tan, N Yang, TL Krishnamoorthy, V Oei, A Chua, X Zhao, HS Tan, ... Gastroenterology 156 (6), 1862-1876. e9, 2019 | 114 | 2019 |
| Intrinsic functional potential of NK-cell subsets constrains retargeting driven by chimeric antigen receptors VYS Oei, M Siernicka, A Graczyk-Jarzynka, HJ Hoel, W Yang, D Palacios, ... Cancer immunology research 6 (4), 467-480, 2018 | 83 | 2018 |
| Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells LL Liu, V Béziat, VYS Oei, A Pfefferle, M Schaffer, S Lehmann, ... Cancer Immunology Research 5 (8), 654-665, 2017 | 69* | 2017 |
| Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies G Suck, VYS Oei, YC Linn, SH Ho, S Chu, A Choong, M Niam, MBC Koh Experimental Hematology 39 (9), 904-914, 2011 | 49 | 2011 |
| Harnessing adaptive natural killer cells in cancer immunotherapy LL Liu, A Pfefferle, VOY Sheng, AT Björklund, V Béziat, JP Goodridge, ... Molecular oncology 9 (10), 1904-1917, 2015 | 43 | 2015 |
| Spatiotemporal differences in presentation of CD8 T cell epitopes during hepatitis B virus infection A Khakpoor, Y Ni, A Chen, ZZ Ho, V Oei, N Yang, R Giri, JX Chow, AT Tan, ... Journal of virology 93 (4), 10.1128/jvi. 01457-18, 2019 | 34 | 2019 |
| Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA N Mensali, F Ying, VOY Sheng, W Yang, E Walseng, S Kumari, ... Oncoimmunology 5 (5), e1138199, 2016 | 7 | 2016 |
| Splice-switching antisense oligonucleotides as a targeted intrinsic engineering tool for generating armored redirected T cells E Ceccarello, T Tabaglio, S Koh, V Oei, W Teo, OJ Jonathan, A Pavesi, ... Nucleic acid therapeutics 31 (2), 145-154, 2021 | 4 | 2021 |
| Modulation of secretory lysosomes during NK cell education leads to accumulation of granzyme B and enhanced functional potential JP Goodridge, B Jacobs, ML Saetersmoen, D Clement, T Clancy, ... bioRxiv, 305862, 2018 | 3 | 2018 |
| Personalized T cell therapy against HBV-related hepatocellularcarcinoma A Tan, T Krishnamoorthy, N Yang, D Low, YL Tham, A Khakpoor, ... Journal of Hepatology 68 (18), 30242-3, 2018 | 3 | 2018 |
| Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires C Philippon, S Tao, D Clement, A Haroun-Izquierdo, KM Kichula, ... Blood Advances 7 (16), 4492-4504, 2023 | 2 | 2023 |
| TRPML1-mediated modulation of dense-core granules tunes functional potential in NK cells JP Goodridge, B Jacobs, ML Satersmoen, D Clement, T Clancy, ... bioRxiv, 2018 | 2 | 2018 |
| Engineering NK Cells Towards Next Generation NK Cell Immunotherapy VYS Oei | | 2018 |
| Preferential recognition of hepatitis B virus-DNA integrated target by hepatitis B virus-specific CD8 T cells A Khakpoor, Y Ni, ZZ Ho, V Oei, EA Felinska, N Yang, JX Chow, CT Lim, ... Journal of Hepatology 1 (66), S326, 2017 | | 2017 |
| Killer immunoglobulin-like receptors (KIRS) on 3rd trimester decidual natural killer cells GM Johnsen, VOY Sheng, K Taskén, AC Staff, KJ Malmberg Journal of Reproductive Immunology, 11, 2015 | | 2015 |
| Interleukin-15 supports long-term cultures for generation of highly potent clinical grade NK effectors for targeting haematological malignancies G Suck, VYS Oei, YC Linn, A Choong, S Chu, M Niam, MBC Koh BONE MARROW TRANSPLANTATION 45, S298-S299, 2010 | | 2010 |
Jode GoodridgeFate TherapeuticsVerified email at fatetherapeutics.com
